Physician profile
David Michael Jackson
NPI 1629165170
$3,809.97
in general payments reported to CMS, 2019-2025
8 companies · $81.12 in 2025
The $81.12 reported for 2025 was more than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.00 · 2021: $1,370 · 2023: $2,283 · 2024: $50.74 · 2025: $81.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,038 · Food and Beverage: $877 · Entertainment: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,037.50 |
| Food and Beverage | $877.38 |
| Entertainment | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,079.19 | 2019-2023 | |
| Patterson Companies, INC. | $1,367.65 | 2021-2025 | |
| Ultradent Products INC | $165.18 | 2021-2024 | |
| Straumann USA LLC | $127.22 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $26.51 | 2025 | Biohorizons Dental Implants |
| Zimvie INC. | $15.81 | 2023 | |
| Sonendo INC | $14.44 | 2023 | Gentlewave Console |
| Solventum Corporation | $13.97 | 2024 | 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.